These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37619667)

  • 1. Orthokeratology vs. orthokeratology combined with atropine for the control of myopia in children: systematic review.
    Zambrano Peralta P; Ortiz Quito M; Guerrero Ortiz F; Cervantes Anaya L
    Arch Soc Esp Oftalmol (Engl Ed); 2023 Oct; 98(10):568-576. PubMed ID: 37619667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy of Atropine Combined With Orthokeratology in Slowing Axial Elongation of Myopia Children: A Meta-Analysis.
    Gao C; Wan S; Zhang Y; Han J
    Eye Contact Lens; 2021 Feb; 47(2):98-103. PubMed ID: 33060414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis.
    Wang Z; Wang P; Jiang B; Meng Y; Qie S; Yan Z
    PLoS One; 2023; 18(7):e0282286. PubMed ID: 37494360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low concentration atropine combined with orthokeratology in the treatment of axial elongation in children with myopia: A meta-analysis.
    Yang N; Bai J; Liu L
    Eur J Ophthalmol; 2022 Jan; 32(1):221-228. PubMed ID: 33678055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial.
    Tan Q; Ng AL; Choy BN; Cheng GP; Woo VC; Cho P
    Ophthalmic Physiol Opt; 2020 Sep; 40(5):557-566. PubMed ID: 32776533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control.
    Vincent SJ; Tan Q; Ng ALK; Cheng GPM; Woo VCP; Cho P
    Ophthalmic Physiol Opt; 2020 Nov; 40(6):728-737. PubMed ID: 32888318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 0.01% atropine and orthokeratology on ocular axial elongation for myopia children: A meta-analysis (a PRISMA-compliant article).
    Yu Y; Liu J
    Medicine (Baltimore); 2022 May; 101(18):e29191. PubMed ID: 35550467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial.
    Tan Q; Ng AL; Cheng GP; Woo VC; Cho P
    Cont Lens Anterior Eye; 2023 Feb; 46(1):101723. PubMed ID: 35654683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Atropine with Orthokeratology for Myopia Control: Study Design and Preliminary Results.
    Tan Q; Ng AL; Cheng GP; Woo VC; Cho P
    Curr Eye Res; 2019 Jun; 44(6):671-678. PubMed ID: 30632410
    [No Abstract]   [Full Text] [Related]  

  • 10. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.
    Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A
    Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: A systematic review and network meta-analysis.
    Tsai HR; Wang JH; Huang HK; Chen TL; Chen PW; Chiu CJ
    J Formos Med Assoc; 2022 Dec; 121(12):2490-2500. PubMed ID: 35688780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial.
    Yuan Y; Zhu C; Liu M; Zhou Y; Yang X; Zheng B; Li Z; Mao X; Ke B
    Trials; 2021 Dec; 22(1):863. PubMed ID: 34852833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Orthokeratology with Atropine for Children with Myopia: A Meta-Analysis.
    Wang S; Wang J; Wang N
    Ophthalmic Res; 2021; 64(5):723-731. PubMed ID: 32781450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis.
    Gao Y; Yu Y
    Medicine (Baltimore); 2022 Jun; 101(22):e29409. PubMed ID: 35665735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Add-On Effect of 0.01% Atropine in Orthokeratology Wearers for Myopia Control in Children: A 2-Year Retrospective Study.
    Du L; Chen J; Ding L; Wang J; Yang J; Xie H; Xu X; He X; Zhu M
    Ophthalmol Ther; 2023 Oct; 12(5):2557-2568. PubMed ID: 37405578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synergistic efficacy and safety of combined low-concentration atropine and orthokeratology for slowing the progression of myopia: A meta-analysis.
    Zheng NN; Tan KW
    Ophthalmic Physiol Opt; 2022 Nov; 42(6):1214-1226. PubMed ID: 35919929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial.
    Yu S; Du L; Ji N; Li B; Pang X; Li X; Ma N; Huang C; Fu A
    BMC Ophthalmol; 2022 Nov; 22(1):438. PubMed ID: 36380280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Combined Effect of Low-dose Atropine with Orthokeratology in Pediatric Myopia Control: Review of the Current Treatment Status for Myopia.
    Sánchez-González JM; De-Hita-Cantalejo C; Baustita-Llamas MJ; Sánchez-González MC; Capote-Puente R
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32722266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Administration of 0.02% Atropine and Orthokeratology for Myopia Control.
    Lyu Y; Ji N; Fu AC; Wang WQ; Wei L; Qin J; Zhao BX
    Eye Contact Lens; 2021 Feb; 47(2):81-85. PubMed ID: 32443010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.